City
San Diego
43 published announcements name San Diego. The city or office the release names.
Most recent
SEARCH ALL 43 Latham & Watkins Advises Wonder on Its Strategic Partnership With DoorDash 17 Sept 2026
Latham & Watkins Advises Wynn Resorts on US$900 Million Senior Notes Offering 17 Sept 2026
Latham & Watkins Advises Nestlé on US$1 Billion Sale of Holistic Health Portfolio to Yellow Wood 3 Sept 2026
Latham Represents ONEOK on US$4.425 Billion Acquisition of Brazos Midstream 1 Sept 2026
Latham Advises DAZN on Acquisitions of EverPass Media and ViewLift 28 Aug 2026
Latham & Watkins Advises on Oversubscribed US$150 Million Private Placement in Connection With Werewolf Therapeutics and Ambros Therapeutics’ Reverse Merger Transaction 24 Aug 2026
Latham Advises Gossamer Bio on Up to US$250 Million Structured Private Placement, Including US$150 Million of Committed Capital 21 Aug 2026
Latham & Watkins Represented Cox Communications in Completed Combination With Charter Communications 21 Aug 2026
Latham & Watkins Advises Veritas Capital on US$1.1 Billion Sale of Epiq Solutions to TTM Technologies 19 Aug 2026
Latham Advises Frazier Life Sciences on Private Placement Financing in Connection With Fulcrum Therapeutics and Slate Medicines Merger 18 Aug 2026
DLA Piper advises Monaco Enterprises on its US$120 million acquisition by Perimeter Solutions 15 Aug 2026
Latham & Watkins Advises Kard Financial on Acquisition by Citi 15 Aug 2026
Latham & Watkins Advises Dorsch Global on the Sale of Vela Tech 15 Aug 2026
Latham & Watkins Advises The Farmer’s Dog in Acquisition of Woof 10 Aug 2026
Latham & Watkins Advises on BlossomHill Therapeutics’ Upsized US$150 Million IPO 10 Aug 2026
Latham & Watkins Advises Sequoia Capital on Valar Atomics’ US$1 Billion Series B Financing 6 Aug 2026
Latham & Watkins Advises CordenPharma on Acquisition of AmbioPharm 4 Aug 2026
Latham Advises on Scribe Therapeutics’ US$155.51 Million IPO 28 Jul 2026
Latham & Watkins Advises Glenfarne on US$500 Million Investment in Texas LNG by HPS Investment Partners 27 Jul 2026
Latham Advises Crusoe on Partnership With ON.energy to Power AI infrastructure 24 Jul 2026
DLA Piper advises Kira Pharmaceuticals on merger with Jasper Therapeutics 23 Jul 2026
DLA Piper advises on real estate financing for Public Storage’s US$10.5 billion acquisition of National Storage Affiliates 23 Jul 2026
Latham Advises Crystalys Therapeutics on US$130 Million Series B Financing 23 Jul 2026
Latham & Watkins Advises Erasca on US$550 Million Upsized Public Offering of Common Stock 15 Jul 2026
Latham Advises Carlyle on Sale of Copia Power to EQT 13 Jul 2026
DLA Piper advises Andreessen Horowitz on US$30 million investment in Prosper AI 30 Jun 2026
DLA Piper advises Cantor Fitzgerald on Gossamer Bio’s exchange offer and consent solicitation 30 Jun 2026
Latham & Watkins Advises NextDecade in US$3.5 Billion Rio Grande LNG Senior Secured Notes Offering 30 Jun 2026
Latham & Watkins Advises Sony Pictures Entertainment in US$100 Million Strategic Investment in Cosm 30 Jun 2026
Latham Advises on RQ Bio’s US$115 Million Series A Financing 30 Jun 2026
Latham Advises Agility Robotics on US$2.5 Billion Merger With Churchill Capital Corp XI 25 Jun 2026
Latham & Watkins Advises cAMPfield on US$180 Million Series A 19 Jun 2026
Latham & Watkins Advises on Dawn Aerospace’s US$25 Million Series B 19 Jun 2026
Latham & Watkins Advises on US$7 Billion Equity and Equity‑Linked Financing Transactions for Supermicro 12 Jun 2026
Latham & Watkins Advises IDEAYA Biosciences on US$300 Million Offering of Common Stock and Pre‑Funded Warrants 11 Jun 2026
Sidley Represents Equity Group Investments on Exit of Its Investment in CBX to Grupo Aeroportuario del Pacífico in US$2.2 Billion Transaction 8 Jun 2026
DLA Piper advises GigCapital7 Corp. on closing of business combination with Hadron Energy 8 Jun 2026
DLA Piper advises Rare Earths Americas on US$69 million upsized initial public offering 5 Jun 2026
DLA Piper advises NextHome on its acquisition by eXp World Holdings 5 Jun 2026
DLA Piper advises Fixated on acquisition of Studio71 5 Jun 2026
Latham & Watkins Advises on Impulse Space’s US$500 Million Series D 4 Jun 2026
Latham & Watkins Advises Caesars Entertainment in US$17.6 Billion Sale to Fertitta Entertainment 31 May 2026
Latham & Watkins Advises Exa in US$250 Million Series C at US$2.2 Billion Valuation 25 May 2026